The firm won the public affairs account after a competitive bid with three other communications firms, said Jonah Houts, chairman and executive director of the coalition. He declined to provide the name of the finalist firms.
“Gibraltar demonstrated proven capabilities," said Houts. "They understand communications in the 21st century."
The coalition, which was formed in 2002, represents generic drug companies, as well as health insurers, pharmacy benefit managers, large employers, and specialty pharmacy providers.
Houts noted that one of the organization's primary policy issues is cost containment and much of the coalition's public affairs work focuses on communicating that message to policymakers. He would not comment on the budget but confirmed it is in the six-figure range.
Gibraltar has worked with Teva Pharmaceuticals, a generic drug company, since 2008.
Eric Bovim, CEO of Gibraltar Associates, said the firm will evaluate the coalition's overall communications function and strategy, including the possibility of a social media program and the relaunch of its website.